Dr. Moxey-Mims is Chief of the Division of Nephrology at Children’s National Health System, Washington, D.C. She was previously at the National Institute of Diabetes, and Digestive, and Kidney Diseases at the National Institutes of Health in Bethesda, MD. There, she was Deputy Director for clinical science in the Division of Kidney, Urologic, and Hematologic Diseases, and Director of the Pediatric Nephrology program. Two of the studies that she initiated, are the ongoing Chronic Kidney Disease in Children (CKiD) study, the largest study of pediatric chronic kidney disease ever conducted in North America, and the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) trial, a large trial undertaken to understand the effectiveness of prophylactic antimicrobial treatment in children with vesicoureteral reflux. In addition she managed the division’s small business grants for kidney research.

Dr. Moxey-Mims’ focus at Children’s is clinical research to improve the care of children with kidney disease, and as a tool to educate trainees. She received her undergraduate degree from McGill University in Montreal, Canada and her medical degree from Howard University in Washington, D.C. She completed her pediatric residency and clinical pediatric nephrology training at Children’s National, followed by a research fellowship at the National Institute of Allergy and Infectious Diseases at the NIH. She is board-certified in Pediatrics and Pediatric Nephrology and is a member of several national committees. Dr. Moxey-Mims currently serves as Steering Committee Chair of the NIH-sponsored APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) study.